Winnove amélioree l’efficacité thérapeutique de la contention orthodontique et garantit le sourire de 34 millions de patients
Menu
Hephaistos-Pharma is developing a new generation of immunostimulant to treat metastatic and hardly accessible tumors
Kimialys offers an innovative, patented chemical coating that improves the reliability of diagnostic tests.
Odimma develops personalized immunotherapy using AI and synthetic DNA technology.
Abcely develops innovative medical and pharmaceutical technologies for the treatment of mucosal cancers.
Alga Therpeutics produces cancer-fighting antibodies from micro-algae.
A new generation of digital solutions for pain management throughout the patient journey.
Wheeleo is developing an innovative walking aid solution for greater independence and reduced risk of falls.
Genexpath produces and markets cancer characterization kits combined with results analysis software.
Healshape is developing a personalized, natural, regenerative and resorbable bioprosthesis for women who have undergone a mastectomy following breast cancer.
Tele-rehabilitation solutions for patients with long-term conditions.
Open Stent Solution est à l’origine de la première valve mitrale stentée en forme de ruban pour un remplacement transcathéter.
Apmonia Therapeutics is developing a pipeline of next-generation peptide therapies targeting the tumor microenvironment to improve the lives of cancer patients.
"We believe that when it comes to seed financing in the healthcare sector, an innovative start-up can effectively benefit from the support of such a specialized investor, as they understand the specificity of our business model much better than generalist business angels or family office and they are more flexible than life science VCs."
"Angels Santé, in addition to other investors, has given Abcely credibility for its project in the eyes of other, more generalist co-investors, less able to appreciate the real challenges that can be encountered by a biotech company in the healthcare field, more specifically in oncology."
"Angel Santé gives you access to a network of professional investors in the healthcare sector who are keen to get involved in your company's development. Beyond financing, you gain access to invaluable skills in a sector of expertise."
The club offers quarterly physical meetings, co-hosted by entrepreneurs themselves. You benefit from their feedback on a specific theme.
Sessions are co-hosted by other speakers (associate corporate members, ecosystem players, etc.) sharing their expertise.
ANGELS SANTE
24-30 Boulevard Pasteur – Villa M – 75015 Paris
